ClinicalTrials.gg
RecruitingNCT06005272MiNESS20-28Updated Feb 27, 2026

Mothers Working to Prevent Early Stillbirth Study 20-28

An observational study in Stillbirth and Fetal Death and Perinatal Death, sponsored by University of Manchester. Recruiting at 1 site in United Kingdom. Open to female participants aged 16 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by University of Manchester · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
948
Ages
16 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Stillbirth with a site in United Kingdom — 4 open to participants now, 4 under way, none of them phase 3. Stillbirth · United Kingdom.

Planned enrollment
8th of 14
948 · median 989
Started
2023
with 2 others
Observational
14 of 16
4 open now
Registered
14th of 16
by date
Lead sponsor
5 of 16
University of Manchester

Among the 16 studies in Stillbirth with a site in United Kingdom, this one is the 8th largest by planned enrollment of the 14 observational ones that give a count, is one of 3 that started in 2023, is one of 14 observational ones, and was the 14th registered.

Stillbirth

121 studies on the registry are indexed under Stillbirth; 34 are open to participants now.

Browse Stillbirth studies →

Open to participants now

4 of the 16 studies in Stillbirth with a site in United Kingdom are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 24 Stillbirth studies recruiting now, 10 (42%) set no upper age limit and 14 (58%) stop at 75 or younger; 10 take children under 18; 10 take healthy volunteers.

This study: 16 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Stillbirth with a site in United Kingdom, or all of them as a file.
02

Study summary

This project aims to identify factors linked to pregnancy losses occurring between 20 and 28 weeks of pregnancy that can be modified by changing mother's behaviour or healthcare provision.

The death of a child before birth (also called stillbirth or miscarriage) has enduring psychological, social and economic effects for women, their families and wider society. In 2015, the stillbirth rate in the UK was higher than comparable countries. The UK government has committed to reduce stillbirths by 50% by 2025. Presently, stillbirths after 28 weeks of pregnancy have reduced by 16% but there has been no change in losses between 20 and 28 weeks of pregnancy with 1,600 losses estimated to occur at this stage of pregnancy each year.

Identification of modifiable causes of stillbirth was identified as a research priority by the Stillbirth Priority Setting Partnership which involved over 1,000 participants, one third of whom were bereaved parents. The investigators previously completed a study of 291 women who had a late stillbirth (after 28 weeks of pregnancy) and 733 women who had a live baby in 41 maternity units in the UK. This study identified factors linked to stillbirth which can be changed including the position women go to sleep in, cigarette smoking and caffeine consumption. In addition, the investigators previously found changes in mother's perception of baby's movements, whether women had tests for diabetes or whether women were exposed to domestic violence or stressful situations. These factors can be addressed by different care in pregnancy. Information from this study has been included in national and international guidelines that aim to reduce stillbirth.

The investigators will use the same study type to identify factors associated with pregnancy loss between 20 and 28 weeks of pregnancy (early stillbirth). The investigators have asked parents who have experienced the death of a baby at these stages of pregnancy about the design of the study, the questions that would be asked and how best to approach bereaved parents. This led us to include miscarriages from 20-22 weeks of pregnancy that are not usually "counted" in UK stillbirth statistics. The investigators will need 316 women with stillbirth between 20 and 28 weeks of pregnancy and 632 women with an ongoing live pregnancy to participate in the study. All women will complete a questionnaire about themselves, their diet, behaviours and sleep, their baby's movements and pregnancy care. The investigators will compare information between women who have early stillbirth and those who have a live birth to identify factors associated with stillbirth at less than 28 weeks of pregnancy. The study findings will be disseminated in collaboration with patient organisations using effective ways to reach pregnant women. The investigators anticipate the findings from this study will be included in clinical practice guidelines and rapidly translated into antenatal care.

Read the detailed description

Research question What are the modifiable risk factors for early stillbirth (between 20-28 weeks' gestation)?

Background The NHS Long Term Plan sets a goal to reduce stillbirth by 50% by 2025 (from 2013 rates). Some progress has been made with reduction of stillbirths in late pregnancy (≥28 weeks' gestation). However, rates of early stillbirth (\<28 weeks' gestation) remain intractable and new initiatives to reduce early stillbirth rates are needed to achieve this goal. Our previous study (MiNESS) informed about modifiable risk factors for stillbirth ≥28 weeks' gestation and were incorporated into national guidance to reduce stillbirth. However, there is an evidence gap related to modifiable risk factors for early stillbirth.

Aims and Objectives The overall aim of the study is to

  1. Identify modifiable risk factors for early stillbirth that are amenable to public health campaigns or adaptation of antenatal care.

    The study will specifically,

  2. Confirm or refute whether modifiable behavioural factors associated with late stillbirth are also independently associated with early stillbirth.
  3. Explore interactions between maternal characteristics (especially those relating to health inequalities including ethnicity and socioeconomic deprivation), fetal factors (including fetal growth restriction, reduced fetal movements) and early stillbirth risk.
  4. Determine differences in risk factor profiles by cause of death.

Methods This study uses a case-control design based upon that successfully used in the MiNESS study. The eligible population are women with a non-anomalous singleton pregnancy. "Cases" are women who have a stillbirth between 20+0 and 27+6 weeks' gestation and "Controls" are women who have an ongoing viable pregnancy at an equivalent gestational age. Controls will be randomly selected from participating maternity units' booking list at the appropriate week of pregnancy to match the unit's historic distribution of early stillbirths in a 1:2 (case:control) ratio. The study will recruit 316 cases and 632 controls; this gives 80% power to detect associations with an odds ratio ≥1.5. Participants will complete a researcher-administered questionnaire and relevant data will be extracted from medical records. Cases will be approached before hospital discharge, aiming to complete the research interview where possible within 3 weeks.

Unadjusted associations between early stillbirth and each exposure will be calculated. Logistic regression models, adjusted for confounding variables, will consider multiple exposures in relation to early stillbirth.

03

Conditions studied

  • Stillbirth and Fetal Death
  • Perinatal Death
04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Women who have experienced an early stillbirth and women who have an ongoing pregnancy at gestations matched to the profile of women who experienced an early stillbirth from participating maternity units in the UK.

Eligibility criteria

Cases

  • Bereaved mothers/parents who have recently birthed a singleton baby who died before/during or immediately after labour between 20 and 28 weeks of pregnancy.
  • Baby has no evidence of congenital anomaly
  • Able to give written

Controls

  • Pregnant women/people with an ongoing pregnancy (at the target gestation) receiving antenatal care from a participating maternity unit, at a gestation matched to the distribution of stillbirths between 20 to 28 weeks of pregnancy in the same unit
  • Baby has no evidence of congenital anomaly
  • Able to give written informed consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
948 participants (estimated)
Patient registry
No

Groups and cohorts

  • Cases

    Recently pregnant women/people who have experienced baby loss during pregnancy, labour or shortly after birth between 20-28 weeks of pregnancy

    Other: Questionnaire

  • Controls

    Individuals still pregnant at same gestational age

    Other: Questionnaire

Interventions

  • OtherQuestionnaire

    Interviewer assisted completion of questionnaire.

06

What researchers measure

Primary outcomes

  1. Maternal sleep position during pregnancy

    Self-reported sleep position

    Time frame: The night prior to questionnaire or the night prior to pregnancy loss

  2. Duration of sleep during pregnancy

    Self-reported duration of sleep

    Time frame: The night prior to questionnaire or the night prior to pregnancy loss

  3. Presence of snoring during pregnancy

    Self-reported presence of snoring during pregnancy

    Time frame: The night prior to questionnaire or the night prior to pregnancy loss

Secondary outcomes

  1. Maternal perception of fetal movement frequency

    Self-reported perception of frequency of fetal activity

    Time frame: Two-weeks prior to questionnaire or two weeks prior to pregnancy loss

  2. Maternal perception of fetal movement strength

    Self-reported perception of strength of fetal activity

    Time frame: Two-weeks prior to questionnaire or two weeks prior to pregnancy loss

  3. Maternal caffeine exposure

    Self-reported intake of caffeinated drinks

    Time frame: One month prior to questionnaire

  4. Engagement with antenatal care

    Number of appointments with health professionals

    Time frame: Duration of Pregnancy (from booking to the time interview)

  5. Exposure to Intimate Partner Violence

    Self-reported exposure to abusive behaviour using standardised questions

    Time frame: Duration of Pregnancy (from booking to the time interview)

07

Study locations

1 of 1 sites recruiting
  • Manchester University NHS Foundation Trust
    Manchester, M13 9WL, United Kingdom
    Recruiting
    • Linda Peacock, RM · Contact01617016965
08

References and documents

Publications

  • Heazell AE, Wilkinson J, Morris RK, Simpson N, Smith LK, Stacey T, Storey C, Higgins L. Mothers working to prevent early stillbirth study (MiNESS 20-28): a case-control study protocol. BMJ Open. 2024 Jan 18;14(1):e082835. doi: 10.1136/bmjopen-2023-082835. PubMed 38238057 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — Awaiting clearance from the Health Research Authority to share anonymised data for IPD.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Mar 2026, 30 months after the start.

Of 30 observational studies under Stillbirth, half reached primary completion within 91 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 122. This study's planned 30 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 9, 2023
First posted
Aug 22, 2023
StartActual
Sep 1, 2023
Primary completionEst.
Mar 31, 2026
CompletionEst.
Mar 31, 2027
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06005272
Responsible party
Dr Alexander Heazell (Professor of Obstetrics, University of Manchester) — Principal investigator
First posted
Aug 22, 2023
Start date
Sep 1, 2023
Primary completion
Mar 31, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Feb 27, 2026

Study contacts

Alexander E Heazell, PhD
Contact
alexander.heazell@manchester.ac.uk
+441612646484
Lucy Higgins, PhD
Contact
lucy.higgins@manchester.ac.uk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion